Home
Drugs
Trastuzumab
Clinical Trials

Clinical Trials Related to Trastuzumab

Related studies linked through entity extraction aliases.

Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy

Status: COMPLETED
Phase: PHASE1

Trastuzumab in Treating Older Women With Early-Stage Breast Cancer

Status: COMPLETED
Phase: PHASE2

Chemotherapeutic Agents in Brain/Breast

Status: COMPLETED
Phase: N/A

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE1

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Status: COMPLETED
Phase: PHASE3

Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery

Status: COMPLETED
Phase: PHASE2

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Status: COMPLETED
Phase: PHASE3

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Status: COMPLETED
Phase: N/A

Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)

Status: COMPLETED
Phase: PHASE2

Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer

Status: COMPLETED
Phase: PHASE2

Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer

Status: UNKNOWN
Phase: PHASE3

A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)

Status: COMPLETED
Phase: PHASE2

A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease

Status: COMPLETED
Phase: PHASE2

Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery

Status: TERMINATED
Phase: PHASE2

Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE2

Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE3

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

Status: COMPLETED
Phase: PHASE3

Trastuzumab Optimization Trial in Breast Cancer

Status: UNKNOWN
Phase: PHASE3

Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer

Status: COMPLETED
Phase: PHASE2